Amid Growing Pandemic Fears, Moderna Gets BARDA Funding For Flu Program

The biotech got a $176m award for its pandemic influenza vaccine program through BARDA’s Rapid Response Partnership Vehicle.

• Source: Shutterstock

Efforts to develop vaccines against pandemic influenza as the virus rapidly spreads among livestock in the US received a push on 2 July as Moderna, Inc. obtained a project award from the Department of Health and Human Services’ Biomedical Advanced Research and Development Authority’s Rapid Response Partnership Vehicle (RRPV) for its pandemic flu vaccine program.

More from Anti-infective

More from Therapy Areas